Skip to content
Sensei Biotherapeutics
Clinical-Stage Biotechnology
About
Pipeline
Overview
SNS-101 (VISTA)
SNS-401-NG
SNS-VSIG4
Presentations
Platform
TMAb Platform
ImmunoPhage Platform
Therapeutic cocktails
Phortress
Immunophage + Nanobodies
GMP Manufacturing
Publications
Our Leadership
Senior Leadership
Board Of Directors
Immuno Oncology Advisory Board
Careers
Investors and Media
News Releases
Events & Presentations
Corporate Governance
Governance Overview
Board of Directors
Management
Committee Composition
Financial Information
Sec Filings
Stock Information
Stock Quote & Chart
Analyst Coverage
Shareholder Service
Investor FAQs
Email Alerts
RSS Feeds
Contact Us
Contact
About
Pipeline
Overview
SNS-101 (VISTA)
SNS-401-NG
SNS-VSIG4
Presentations
Platform
TMAb Platform
ImmunoPhage Platform
Therapeutic cocktails
Phortress
Immunophage + Nanobodies
GMP Manufacturing
Publications
Our Leadership
Senior Leadership
Board Of Directors
Immuno Oncology Advisory Board
Careers
Investors and Media
News Releases
Events & Presentations
Corporate Governance
Governance Overview
Board of Directors
Management
Committee Composition
Financial Information
Sec Filings
Stock Information
Stock Quote & Chart
Analyst Coverage
Shareholder Service
Investor FAQs
Email Alerts
RSS Feeds
Contact Us
Daily Archives:
November 13, 2021
SITC 2021: Preclinical data for SNS-101
Presentation
By
spb_dev
November 13, 2021
…
Go to Top